000 01161 a2200349 4500
005 20250513090532.0
264 0 _c19960625
008 199606s 0 0 eng d
022 _a0939-5555
024 7 _a10.1007/s002770050172
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDe Pauw, B E
245 0 0 _aAntibiotic strategy after the empiric phase in patients treated for a hematological malignancy.
_h[electronic resource]
260 _bAnnals of hematology
_cApr 1996
300 _a273-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aFever
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aLeukemia
_xcomplications
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeutropenia
_xdrug therapy
700 1 _aDompeling, E C
773 0 _tAnnals of hematology
_gvol. 72
_gno. 4
_gp. 273-9
856 4 0 _uhttps://doi.org/10.1007/s002770050172
_zAvailable from publisher's website
999 _c8623428
_d8623428